Scientists have uncovered a natural braking system that helps the immune system switch off inflammation and prevent harmful immune cells from building up. Boosting this pathway in people reduced inflammation-related immune changes and sped up pain relief, pointing toward potential new treatments for chronic inflammatory diseases.

First author Dr. Olivia Bracken (UCL Department of Ageing, Rheumatology and Regenerative Medicine) said: "Our findings reveal a natural pathway that limits harmful immune cell expansion and helps calm inflammation more quickly.

“Targeting this mechanism could lead to safer treatments that restore immune balance without suppressing overall immunity. With chronic inflammation ranked as a major global health threat, this discovery opens a promising avenue for new therapies.”

  • Verqix
    2·
    3 days ago

    The people who did the work? Like the researchers at Novo that mainly just get salary? Let them have their salary, patents and scientific recognition. That is their credit.

    Indeed Novo has built upon a lot of research and most of that is publicly funded. The price of the drug of course should recompense the organization for costs in research, trials and approval.

    Still it is strange that costs to the consumer are 9 times higher on the US market than in Europe.

    Also, it’s strange that capitalisation is so free in making money that high prices are required to attract capital for helping and healing people. Human lives are worth less than profits. Gross amounts of money are making their way to sociopaths. You are downplaying a very real and sad state of affairs with “but money must be made”. Sadly that is the state of things, but you put it as if this is as it should be.

    Insulin was named as an example which you gloss over, where research wasn’t needed and production could be optimized for larger profits, but prices were raised to the point of people cutting back on their intake. This has caused bodily damage, loss of eyesight, loss of life. This wasn’t to the benefit of the working people, and to the deficit of patients.

    • iopq
      11·
      3 days ago

      Yes, but the investors that invested their money to pay those salaries expect a return on their investments. If they couldn’t make the profits, people wouldn’t buy the stock. Other pharmas wouldn’t be able to IPO or be acquired since there would be no money in pharma

      • FuglyDuckEnglish
        2·
        3 days ago

        You understand that when the government helps fund things like research thst is an investment?

        Right? Are you just trolling everyone? Or do you really believe that our job is to solely suck off billionaire dick as they price us out of healthcare and let us die.

        Get your head out of Novo’s ass. They’re probably not paying you enough.

        • iopq
          1·
          2 days ago

          Yes, the government does this for the good of humanity. Are you saying they should demand money from Novo Nordisk?

      • Verqix
        1·
        3 days ago

        As I said above: You are downplaying a very real and sad state of affairs with “but money must be made”. Sadly that is the state of things, but you put it as if this is as it should be.

        You are excusing predatory business practices and growing income divide. You are apparently okay with businesses having so much political power they can dictate laws. Regulations and actual sanctions, anti monopoly laws and corruption, unions and raised minimum wages would severely lower the amount of money for investers across the board and the world would be a better place for it.

        You present as something without any empathy. Someone laments the state of things and you say: good way to make a profit and draw investors! Tone deaf.

        • iopq
          1·
          2 days ago

          It’s such a sad state of affairs the obesity rate in America is down for the first time in decades. It’s due to semaglutide